Sign in
or Register nowSchizophreniaConnection.com
Schizophrenia Drugs
FDA panel recommends new bipolar, schizophrenia drug
August 10, 2009
Expert & Community Posts
FDA Claims Pfizer Schizophrenia Drug Ad Misleading
By Christina Bruni , Health ExpertThe FDA has ruled that Pfizer violated the Federal Food, Drug and Cosmetic Act with a false or... Read more »
Drug Prices - Part II
By Robin Cunningham , Health ExpertFor the complete story, read my previous blog: Drug Prices - Part I, posted on December 16th... Read more »
Geodon News
By Christina Bruni , Health ExpertHere, I want to give you an update on the medication change that took place in April, a year to the... Read more »
Cross Titer News
By Christina Bruni , Health ExpertIt's ten o'clock and I write this from my dining table because I'm awake and wanted to talk about... Read more »
Bipolar Thought Deficits: What We Can Learn From Schizophrenia Research
By John McManamy , Health ExpertA few weeks ago, in the Ask feature here at BipolarConnect, Nathan wrote:"Is bipolar the same as... Read more »
Health Guide
Bipolar Medications
...include:Liver damageConvulsionsComaPancreatitisAtypical AntipsychoticsAtypical antipsychotics are standard drugs for schizophrenia. They are now proving to be beneficial for bipolar disorder when... Read more »Schizophrenia: Introduction
In 2007, the Food and Drug Administration approved risperidone (Risperdal) and aripiprazole (Abilify) for treatment schizophrenia in teenagers. These drugs are the first... Read more »Schizophrenia: Treatment
Schizophrenia is categorized as a brain disease, not a psychological disorder, and drug treatment is the primary therapy. Studies indicate, however, that an integrated approach better... Read more »Schizophrenia: Diagnosis
The doctor will use one or more verbal screening tests to help determine whether a patient's symptoms meet the criteria for schizophrenia. Because no single symptom is specific to... Read more »Schizophrenia: References
ReferencesAleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin... Read more »Images
Related News
New schizophrenia drug shows promise in trials
October 02, 2008An experimental schizophrenia drug has shown good results in new clinical trials. The drug, Iloperidone, significantly improved schizophrenia... Read summary »
New schizophrenia drug's trial halted
July 30, 2009Phase III clinical trials on a new drug to treat schizophrenia have been stopped, its makers report. Officials with drugmakers Lundbeck and Solvay... Read summary »
New schizophrenia drug fails in trial
April 01, 2009A new schizophrenia treatment that had shown great promise in earlier studies has failed to work better than a currently used medication or a placebo... Read summary »
New schizophrenia drug shows promise in new study
October 28, 2008A new drug called asenapine has shown positive results in a new clinical trial, its maker has reported. According to a news release from drugmaker... Read summary »
FDA approves new schizophrenia drug
May 09, 2009The U.S. Food and Drug Administration (FDA) has approved a new drug called Fanapt for the treatment of schizophrenia. FDA officials say Fanapt will... Read summary »
- Privacy Policy: Updated as of April 1, 2009|
- Service Terms and Agreement|
- Advertising Policy|
- Contact Us|
- About Us|
- RSS Feed|
- Site Map|
- How to Use This Site
By using this service, you accept our Terms of Use. Please read them. The consumer health information on SchizophreniaConnection.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.
 | We comply with the HONcode standard for trustworthy health information: verify here. |
